Please Wait
Applying Filters...
menu
    • menu
    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Nitisinone (NTBC)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 118,399Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cycle Launches Harliku Tablets for Alkaptonuria (AKU)
    Cycle Launches Harliku Tablets for Alkaptonuria (AKU)

    17 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250716344652/en/Cycle-Pharmaceuticals-launches-HARLIKU-nitisinone-Tablets-the-first-FDA-approved-treatment-for-use-in-Alkaptonuria-AKU

    BUSINESSWIRE
    17 Jul 2025
    Share Share
    Cycle Pharma Harliku Tablets FDA-Approved for Alkaptonuria
    Cycle Pharma Harliku Tablets FDA-Approved for Alkaptonuria

    20 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250611798305/en/Cycle-Pharmaceuticals-HARLIKU-nitisinone-Tablets-Receive-First-FDA-Approval-as-Treatment-for-Alkaptonuria-AKU

    BUSINESSWIRE
    20 Jun 2025
    Share Share
    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2879121/0/en/Eton-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Eton Announces Commercial Availability of Nitisinone Capsules
    Eton Announces Commercial Availability of Nitisinone Capsules

    02 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/02/2822744/0/en/Eton-Pharmaceuticals-Announces-Commercial-Availability-of-Ultra-Rare-Disease-Product-Nitisinone-Capsules.html

    GLOBENEWSWIRE
    02 Feb 2024
    Share Share
    Torrent's Generic Nitisinone Receives Approval in the U.S.
    Torrent's Generic Nitisinone Receives Approval in the U.S.

    09 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215908

    FDA
    09 Jan 2023
    Share Share
    Sobi’s Orfadin Receives Positive Opinion From CHMP For Treatment Of AKU
    Sobi’s Orfadin Receives Positive Opinion From CHMP For Treatment Of AKU

    20 Sep 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131249&sid=2

    PHARMABIZ
    20 Sep 2020
    Share Share